About Us

Welcome to our site. The discovery of an effective treatment for glaucoma requires a collective effort from patients, clinical trial participants, support staff, healthcare professionals, and researchers, among others. We want to hear from you, please email us at team@eliosvision.com.

Our Medical Advisory Board

ike-ahmed

Ike K. Ahmed, MD, FRCSC

Assistant Professor, University of Toronto

keith-barton

Keith Barton, MD, FRCP, FRCS

Ophthalmic Surgeon, Moorfields Eye Hospital, London

rosa-braga-mele

Rosa Braga-Mele MD, MEd, FRCSC

Professor of Ophthalmology, University of Toronto

louis-cantor

Louis B. Cantor, MD

Professor of Ophthalmology, Indiana University

maria-isabel-canut

Maria Isabel Canut, MD

Professor, Barraquer Ophthalmology Center, Barcelona

eric-donnenfeld

Eric Donnenfeld, MD

Co-founder, Ophthalmic Consultants of Long Island & Connecticut

murray-johnstone

Murray Johnstone, MD

Professor, University of Washington

richard-lewis

Richard A. Lewis, MD

Co-founder, Sacramento Eye Consultants

antonio-moreno-valladeres

Antonio Moreno Valladares, MD, PhD

Surgeon, University Hospital of Albacete

thomas-neuhann

Thomas F. Neuhann, MD

Medical Director & Founder, Laser Eye Center, Munich

nathan-radcliffe

Nathan Radcliffe, MD

Surgeon, New York Eye & Ear Infirmary

thomas-samuelson

Thomas W. Samuelson, MD

Partner & Attending Surgeon, Minnesota Eye Consultants

marc-toteberg-harms

Marc Töteberg-Harms, MD, FEBO

Assistant Professor, University of Munich

News

Addressing Glaucoma During Routine Cataract Surgery: The Experts’ Opinions on the Role of ELIOS

To understand the potential of the excimer laser-based ELIOS to improve the outcomes and quality of life of patients with glaucoma, Elios Vision Inc. held a round-table discussion with an international expert group of ophthalmologists.
Read More >

A Vision for a New Era in Combined Glaucoma and Cataract Treatment

A Q&A with Elliot Friedman, CEO or ELIOS Vision, Inc., and Murray Johnstone, MD, a clinical professor at the University of Washington and member of the ELIOS Medical Advisory Board.
Read More >

ELIOS combined with cataract surgery delivers significant IOP reduction out to 8 years

Today, ELIOS Vision, Inc. announced the eight-year follow up results of its novel ELIOS® Excimer Laser Trabeculostomy procedure combined with cataract surgery.
Read More >

ELIOS Vision’s Excimer Laser Trabeculostomy Procedure Receives New CPT Codes from American Medical Association

Two Category III CPT codes are approved to report trabeculostomy ab interno by laser with or without the use of an ophthalmic endoscope. The trabeculostomy procedure restores the “natural flow” of aqueous fluid using the company’s non-thermal, precise excimer laser system, ELIOS ELT.
Read More >

Leading North American and European Glaucoma Leaders Highlight Significant Effectiveness and Favorable Safety Profile of ELIOS in Review Article

Ten independent clinical studies demonstrate significant intraocular pressure (IOP) lowering effect of ELIOS with few complications and no residual device remaining in the angle.
Read More >

ELIOS Vision, Inc. Announces Medical Advisory Board

Glaucoma key opinion leaders join the ELIOS Vision Medical Advisory Board.
Read More >